←
Prof Sam El-Osta2,342 posts
Prof Sam El-Osta avatar

Prof Sam El-Osta

@SamElOsta1

Sam is an epigeneticist dedicated to understanding health and disease. Clinical importance over statistical significance. Baker Heart and Diabetes Institute.

◷ Joined April 2020▧ 103 Photos and videos
Prof Sam El-Osta avatar
Prof Sam El-Osta@SamElOsta1·10 Oct 2025

Grateful for all the recent interest by clinicians and scientists in our Diabetes (ADA) paper: DNA methylation biomarkers in cord blood predict future metabolic risk with 79% greater accuracy than traditional factors. A window into lifelong health. Read: doi.org/10.2337/db25-0105

0:06
Katja Kobow avatar
⟳ Prof Sam El-Osta retweeted
Katja Kobow@KatjaKobow·Jun 9

🚨New preprint out: A novel diagnostic intracranial EEG biomarker in MOGHE medrxiv.org/content/10.64898…. Great multi-center interdisciplinary study with clinical impact. #epilepsy @IlaeWeb

nature avatar
⟳ Prof Sam El-Osta retweeted
nature@Nature·Oct 12

How much do PhD students earn? The first comprehensive overview of PhD income shows vast imbalances across much of Europe Read the full story: nature.com/articles/d41586-0…

Post attachment
Prof Sam El-Osta avatar
Prof Sam El-Osta@SamElOsta1·Oct 11

A long time coming - our DKD epigenetics study is now Online Ahead of Print in Diabetes. Blood DNA methylation score linked to renal epigenomic change. Great collaboration with Peter Rossing & Denmark, and fitting to share from the BT1D CRC meeting. lnkd.in/gzZXyRZn

Post attachment
Prof Sam El-Osta avatar
Prof Sam El-Osta@SamElOsta1·Oct 11

Great to reconnect with friends, Lorenzo Piemonti in Philadelphia with Keith Al-Hasani at #BreakthroughT1D. The challenge ahead is increasingly clear: restore β-cell function, protect it from immune destruction, and translate both into durable insulin independence.

Post attachment
Prof Sam El-Osta avatar
Prof Sam El-Osta@SamElOsta1·Oct 10

Looking forward to the Vertex session at #BT1D on the evolving landscape of #T1D care. The field is moving beyond better insulin replacement toward disease modification, β-cell preservation, cell replacement and immune protection. Question - how far can we change its biology?

Post attachment
Prof Sam El-Osta avatar
Prof Sam El-Osta@SamElOsta1·Oct 10

Day 2 at #BT1D in Philadelphia with friends Tom Loudovaris, Keith Al-Hasani & Tom Kay. Great conversations on the future of #T1D research, β-cell biology, regeneration, immune protection and translation. The goal is bigger than better management: change the biology of T1D.

Post attachment
Prof Sam El-Osta avatar
Prof Sam El-Osta@SamElOsta1·Oct 9

Breakthrough T1D Congress, Philadelphia. October 9-11. Shaping the future of T1D.

0:34
Prof. Nikolai Slavov avatar
⟳ Prof Sam El-Osta retweeted
Prof. Nikolai Slavov@slavov_n·Sep 30

bioRxiv has a dedicated section for negative results. Use it. Share negative results. Your colleagues will appreciate it.

Post attachment
The Lancet avatar
⟳ Prof Sam El-Osta retweeted
The Lancet@TheLancet·Sep 18

What makes a meta-analysis believable? In our latest issue, a new Viewpoint outlines how to identify meta-analyses that merit clinical confidence. Explore the full issue: spkl.io/60197rxth

Post attachment
BioTender avatar
⟳ Prof Sam El-Osta retweeted
BioTender@Junioryu136689·Sep 17

Cell just dropped a full Focus Issue on AI in Biology. Virtual cells. World models. 500M+ cell repositories. 100M-scale perturbation atlases. Aging benchmarks. 4D mitochondria. Multimodal cancer prediction. Here are the 13 pieces worth reading 🧵

Post attachment